Mirati Therapeutics
MRTX
#2969
Rank
$4.11 B
Marketcap
$58.70
Share price
0.00%
Change (1 day)
29.75%
Change (1 year)

Mirati Therapeutics (MRTX) - Cash on Hand

Cash on Hand as of September 2023 : $0.97 B

According to Mirati Therapeutics's latest financial reports the company has $0.97 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Mirati Therapeutics - Cash on Hand chart (from 2005 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31$1.08 B-27.32%
2021-12-31$1.49 B7.28%
2020-12-31$1.39 B234.92%
2019-12-31$0.41 B86.3%
2018-12-31$0.22 B47.7%
2017-12-31$0.15 B165.87%
2016-12-31$56.73 M-53.62%
2015-12-31$0.12 B317.46%
2014-12-31$29.3 M-52.79%
2013-12-31$62.07 M67.83%
2012-12-31$36.98 M30.53%
2011-12-31$28.33 M284.97%
2010-12-31$7.35 M-55.86%
2009-12-31$16.67 M-47.44%
2008-12-31$31.72 M-48.27%
2007-12-31$61.32 M8.67%
2006-12-31$56.43 M149.93%
2005-12-31$22.58 M-34.46%
2004-12-31$34.45 M44.99%
2003-12-31$23.76 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
$0.38 B-60.48%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.13 M-99.99% Bahamas